dermatan sulfate has been researched along with Neuromuscular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Giulio, AM; Germani, E; Gorio, A; Lesma, E; Muller, EE; Rossoni, G | 1 |
| Bertolotto, A; Caterson, B; Mongini, T; Palmucci, L; Schiffer, D | 1 |
2 other study(ies) available for dermatan sulfate and Neuromuscular Diseases
| Article | Year |
|---|---|
Long-term neuroprotective effects of glycosaminoglycans-IGF-I cotreatment in the motor neuron degeneration (mnd) mutant mouse.
Topics: Animals; Atrophy; Cell Count; Cholera Toxin; Dermatan Sulfate; Drug Therapy, Combination; Female; Fluorescent Dyes; Heparitin Sulfate; Horseradish Peroxidase; Insulin-Like Growth Factor I; Male; Mice; Mice, Neurologic Mutants; Motor Neurons; Muscle Fibers, Skeletal; Muscle, Skeletal; Nerve Degeneration; Neuromuscular Diseases; Neuroprotective Agents; Presynaptic Terminals; Rhodamines; Synaptophysin | 1999 |
Chondroitin, chondroitin 6-sulphate, chondroitin 4-sulphate and dermatan sulphate proteoglycans in normal and pathological human muscle.
Topics: Antibodies, Monoclonal; Chondroitin; Chondroitin Sulfate Proteoglycans; Dermatan Sulfate; Humans; Hyaluronoglucosaminidase; Immunohistochemistry; Muscles; Neuromuscular Diseases; Proteoglycans | 1987 |